Breast Cancer Res...
Follow
Find
152 views | +0 today
Breast Cancer Research
Updates on breakthroughs and research for breast cancer
Curated by Brian Shields
Your new post is loading...
Your new post is loading...
Rescooped by Brian Shields from Biomarkers and Personalized Medicine
Scoop.it!

PTEN is an important tumor suppressor gene in breast cancer

PTEN is an important tumor suppressor gene in breast cancer | Breast Cancer Research | Scoop.it
An interesting new paper has just appeared in the latest online first edition of Cancer Discovery, and discusses a functional classification for evaluating the alterations in breast cancer to ultimately determine which are drivers...

Via Brian Shields
more...
No comment yet.
Rescooped by Brian Shields from Biomarkers and Personalized Medicine
Scoop.it!

IU investigators find biomarker that predicts taxane-induced neuropathy among breast cancer patients | cancer

IU investigators find biomarker that predicts taxane-induced neuropathy among breast cancer patients | cancer | Breast Cancer Research | Scoop.it
IU investigators find biomarker that predicts taxane-induced neuropathy among breast cancer patients...

Via Brian Shields
more...
No comment yet.
Rescooped by Brian Shields from Biomarkers and Personalized Medicine
Scoop.it!

Whole-genome sequencing may help fight triple-negative cancer | R&D Mag

Whole-genome sequencing may help fight triple-negative cancer | R&D Mag | Breast Cancer Research | Scoop.it
Initial results from an ongoing clinical trial, the first designed to examine the utility of whole-genome sequencing for breast cancer, indicate activation of targets not previously associated with so-called triple negative disease, which...

Via Brian Shields
more...
No comment yet.
Scooped by Brian Shields
Scoop.it!

Bevacizumab improved PFS in HER-2–positive breast cancer | HemOncToday

Bevacizumab improved PFS in HER-2–positive breast cancer | HemOncToday | Breast Cancer Research | Scoop.it

This is an interesting Phase II trial since plasma VEGF-A  was recognized as a potential biomarker for treatment with bevacizumab.  Hopefully this will be an important stepping stone for future Phase III trials.

more...
No comment yet.
Rescooped by Brian Shields from Biomarkers and Personalized Medicine
Scoop.it!

The CYP2C19*2 genotype predicts tamoxifen treatment outcome in advanced breast cancer patients

The CYP2C19*2 genotype predicts tamoxifen treatment outcome in advanced breast cancer patients http://bit.ly/reQXFV...

Via Brian Shields
more...
No comment yet.
Rescooped by Brian Shields from Biomarkers and Personalized Medicine
Scoop.it!

Redefining subsets of triple negative breast cancer

Redefining subsets of triple negative breast cancer | Breast Cancer Research | Scoop.it
Heterogeneity remains one of the biggest barriers to progress in clinical research. Triple negative breast cancer is an excellent example of this conundrum as I’ve said many times here on this blog – it’s defined not what it is but what it’s not.

Via Brian Shields
more...
No comment yet.
Rescooped by Brian Shields from Biomarkers and Personalized Medicine
Scoop.it!

What’s hot at SABCS – Update 2 – advanced breast cancer

What’s hot at SABCS – Update 2 – advanced breast cancer | Breast Cancer Research | Scoop.it
After a number of basic research and science sessions over the last two days (see the Update 1 post on the science that intrigued me for more details), but the last two days heralded some excellent clinical sessions, in both oral and poster forms.

Via Brian Shields
more...
No comment yet.